Skip to search formSkip to main contentSkip to account menu

SK&F 92657

Known as: SK&F-92657, SKF 92657 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

prizidilol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1985
1985
Discolouration of the Optic Disc in Baboons During Treatment with Prizidilol (SK&F 92657), a Novel Antihypertensive Agent
1 Prizidilol (SK&F 92657-A2.H2O) is the dihydrochloride salt of D,L-3-[2-(3- t-butylamino-2-hydroxypropoxy)phenyl]-6… 
1984
1984
Cardiovascular response to mental stress: dynamic and isometric exercise in hypertensive patients treated with prizidilol hydrochloride (SK&F 92657).
The cardiovascular effects of a new antihypertensive agent, prizidilol hydrochloride (SK&F 92657), have been evaluated in a group… 
1984
1984
Dose-response relationship of prizidilol hydrochloride (SK&F 92657): a comparison between acute and chronic effects in patients with essential hypertension.
Three different doses (50, 100 and 200 mg) of prizidilol hydrochloride (SK&F 92657), a novel antihypertensive agent with… 
1983
1983
Pulmonary effects in man of oral prizidilol hydrochloride (SK&F 92657), a new antihypertensive agent.
The effects on heart rate, blood pressure and pulmonary function of single oral doses of prizidilol hydrochloride (400 mg SK&F… 
1981
1981
Hemodynamic Profile of a New Antihypertensive Agent D,L‐3‐[2‐(3‐t‐Butylamino‐2‐hydroxy‐propoxy)phenyl]‐6‐hydrazinopyridazine (SK&F 92657)
Summary The properties of a new antihypertensive agent, SK&F 92657, D,L-3 – [2-(3-t-butylamino-2-hydroxypropoxy)phenyl]-6… 
1981
1981
Studies on the Autonomic Nervous System with SK&F 92657, a New Antihypertensive Agent Causing Direct Arterial Vasodilatation and β‐Adrenoceptor Blockade
Summary The β-adrenoceptor-blocking properties of SK&F 92657, D,L-3-[2-(3-t-butylamino-2-hydroxypropoxy)phenyl]-6… 
1981
1981
Effects of prizidilol (SKF 92657) on blood pressure, haemodynamics, sympathetic nervous system activity and plasma volume in essential hypertension.
1. The antihypertensive effect of 4 weeks' treatment with prizidilol (SKF 92657) (mean dosage 520 mg once or twice daily) was… 
1981
1981
Prizidilol (SKF 92657) in primary hypertension.
1. Prizidilol (SKF 92657), a new antihypertensive drug with combined precapillary vasodilator and non-selective beta-adrenoceptor… 
1981
1981
Cardiovascular effects in man of intravenous prizidilol hydrochloride (SK&F 92657); a new antihypertensive agent.
1 Cardiovascular responses to intravenous prizidilol hydrochloride (SK&F 92657) 0.86 mg/kg were studied in eight supine resting… 
1979
1979
SK&F 92657, a novel antihypertensive acting by precapillary vasodilatation and beta-adrenoreceptor blockade.
1. The properties of a new antihypertensive agent, SK&F 92657, DL-3-[2-(3-t-butylamino-2-hydroxypropoxy)phenyl]-6… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)